Jersey City, New Jersey, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Verified Market Research® recently published a report, “Artificial Intelligence In Drug Discovery Market” By Technology (Machine Learning, Deep Learning), By Application (Cardiovascular Diseases, Immuno-oncology), By End-User (Contract Research Organizations, Pharmaceutical & Biotechnology Companies), and By Geography.
As per the deep research carried out by Verified Market Research®, the global Artificial Intelligence In Drug Discovery Market size was valued at USD 175.91 Million in 2018 and is projected to reach USD 2,589.81 Million by 2026, growing at a CAGR of 39.9 % from 2019 to 2026.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=29986
Browse in-depth TOC on “Artificial Intelligence In Drug Discovery Market”
202 - Pages
126 – Tables
37 – Figures
Global Artificial Intelligence In Drug Discovery Market Overview
Artificial intelligence is a product of computer-assisted drug development (AI). This expansion is being fueled by the widespread application of machine learning, especially deep learning, in several scientific fields as well as advancements in computer hardware and software. Unlike natural intelligence developed by animals like humans, artificial intelligence is a type of machine intelligence (AI). The study of "intelligent agents," or systems that are aware of their environment and take actions to improve their chances of success, is known as artificial intelligence (AI). The several subfields of artificial intelligence technologies are based on particular objectives and the use of certain methods.
Conventional AI research targets include the development of thinking, information processing, planning, learning, voice recognition, sensing, and the capacity to move and control objects. One of the long-term goals of the area in general intelligence (the ability to solve any problem).
Artificial intelligence in the pharmaceutical industry has the ability to find hit and lead compounds, enhance the design of drug structures, and give quicker confirmation of the medicinal target, all of which are anticipated to increase demand. The determination of relevant interactions in medical testing is also facilitated by AI, which helps to minimize the chance of false positive results through careful parameter design. Another aspect influencing the industry's growth is its capacity to transition pharmaceutical screening from the bench to a virtual lab, where results of a screen can be produced more rapidly and intriguing targets may be found without the need for significant experimental input and labor hours.
The enormous data sets accessible for drug research in pharmaceutical businesses, which contain millions of elements, maybe too much for artificial intelligence algorithms to handle. This is anticipated to slow the development of artificial intelligence in the drug discovery market in the very near future.
Verified Market Research® narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The “Global Artificial Intelligence In Drug Discovery Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Key Players
The “Global Artificial Intelligence In Drug Discovery Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are NVIDIA Corporation, Deep Genomics, IBM Corporation, Cloud Pharmaceuticals, Microsoft, Google, Atomwise, Inc., Insilico Medicine, BenevolentAI, and Exscientia.
Based on the research, Verified Market Research® has segmented the global Artificial Intelligence In Drug Discovery Market into Technology, Application, End-User, and Geography.
- Artificial Intelligence In Drug Discovery Market, by Technology
- Machine Learning
- Deep Learning
- Supervised Learning
- Reinforcement Learning
- Others
- Artificial Intelligence In Drug Discovery Market, by Application
- Cardiovascular Diseases
- Immuno-oncology
- Metabolic Diseases
- Neurodegenerative Diseases
- Others
- Artificial Intelligence In Drug Discovery Market, by End-User
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Research Centers and Academic & Government Institutes
- Artificial Intelligence In Drug Discovery Market, by Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Browse Related Reports:
Gene Expression Market By Consumables (Reagents, DNA Chips), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), By Service (Gene Expression Profiling Services, Bioinformatics Solutions), By Application (Research, Drug Discovery, Diagnostics), By Geography, And Forecast
Cancer Biomarkers Market By Cancer Type (Breast Cancer, Prostate Cancer), By Biomarker-Type (Protein Biomarkers, Genetic Biomarkers), By Profiling Technology (OMICS Technology, Imaging Technology), By Application (Drug Discovery And Development, Diagnostics), By Geography, And Forecast
Anatomic Pathology Market By Product And Service (Instruments, Consumables), By Application (Disease Diagnosis, Drug Discovery And Development), By End-User (Hospitals, Diagnostic Laboratories, Research Laboratories), By Geography, And Forecast
Label-Free Drug Discovery Market By Product (Cellular Dielectric Spectroscopy, Bio-layer Interferometry, Surface Plasmon Resonance, Optical Waveguide Grating Technology), By Application (Pharmaceutical Companies, Research Laboratories, Other), By Geography, And Forecast
Top 10 Next Generation Sequencing Companies changing lives with genome research
Visualize Artificial Intelligence In Drug Discovery Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.
